Efficacy and safety of exenatide once weekly versus metformin, pioglitazone, and sitagliptin used as monotherapy in drug-naive patients with type 2 diabetes (DURATION-4): a 26-week double-blind study.
Tools
Russell-Jones, D, Cuddihy, RM, Hanefeld, M, Kumar, A, González, JG, Chan, M, Wolka, AM, Boardman, MK and DURATION-4 Study Group, (2012) Efficacy and safety of exenatide once weekly versus metformin, pioglitazone, and sitagliptin used as monotherapy in drug-naive patients with type 2 diabetes (DURATION-4): a 26-week double-blind study. Diabetes Care, 35 (2). pp. 252-258.
Full text not available from this repository.Abstract
To test the safety and efficacy of exenatide once weekly (EQW) compared with metformin (MET), pioglitazone (PIO), and sitagliptin (SITA) over 26 weeks, in suboptimally treated (diet and exercise) drug-naive patients with type 2 diabetes.
Item Type: | Article | ||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Authors : |
|
||||||||||||||||||||||||||||||
Date : | February 2012 | ||||||||||||||||||||||||||||||
Identification Number : | 10.2337/dc11-1107 | ||||||||||||||||||||||||||||||
Uncontrolled Keywords : | Diabetes Mellitus, Type 2, Double-Blind Method, Drug Administration Schedule, Female, Humans, Hypoglycemic Agents, Male, Metformin, Middle Aged, Peptides, Pyrazines, Thiazolidinediones, Treatment Outcome, Triazoles, Venoms | ||||||||||||||||||||||||||||||
Depositing User : | Symplectic Elements | ||||||||||||||||||||||||||||||
Date Deposited : | 17 May 2017 09:39 | ||||||||||||||||||||||||||||||
Last Modified : | 17 May 2017 09:39 | ||||||||||||||||||||||||||||||
URI: | http://epubs.surrey.ac.uk/id/eprint/824574 |
Actions (login required)
![]() |
View Item |
Downloads
Downloads per month over past year